Novartis to invest CHF70 million in a new Swiss production unit
The production unit will be developed in an existing building in the Schweizerhalle industrial area on the outskirts of Basel.
Keystone / Gaetan Bally
The Swiss pharmaceutical company has announced that it is constructing a new production unit for experimental drugs on the outskirts of the city of Basel.
This content was published on
1 minute
SDA-Keystone/ac
The CHF70 million (around $77.5 million) investment will give it two new production lines, Novartis said on Tuesday. Both will be dedicated to producing active ingredients for experimental medicines. The production lines will be developed in an existing building in the Schweizerhalle industrial area on the outskirts of Basel.
These new facilities will be commissioned at the end of next year. This investment confirms the importance of Schweizerhalle as a global production site, Novartis said.
Related Stories
Popular Stories
More
Swiss oddities
The Théâtre du Jorat, Switzerland’s ‘sublime barn’
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Covid cure further away than hoped, says Novartis chief
This content was published on
Swiss pharmaceutical firm Novartis has rowed back on earlier predictions that a drug to combat coronavirus could be on the horizon.
This content was published on
Swiss drug giant Novartis is ending its trial of malaria drug hydroxychloroquine against Covid-19 after failing to find enough participants.
This content was published on
Around 1,500 jobs are affected in production and 700 in services. Novartis currently employs 13,000 people across Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.